Physician profile
Pavan Kumar Anand
NPI 1437341187
$8,061.86
in general payments reported to CMS, 2019-2025
47 companies · $1,436 in 2025
The $1,436 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $522 · 2021: $848 · 2022: $1,278 · 2023: $1,667 · 2024: $1,496 · 2025: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,598.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $705.75 | 2022-2023 | Cobalt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $702.69 | 2020-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $691.35 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $665.79 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $651.18 | 2022-2025 | |
| Pfizer INC. | $470.30 | 2020-2024 | |
| Novo Nordisk INC | $437.42 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $367.60 | 2019-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Boston Scientific Corporation | $359.48 | 2022-2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $341.04 | 2019-2021 | |
| Edwards Lifesciences Corporation | $289.37 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Lilly USA, LLC | $242.21 | 2020-2024 | Jardiance, Zepbound, Mounjaro |
| Inspire Medical Systems, INC. | $176.44 | 2022 | |
| Idorsia Pharmaceuticals US INC | $160.13 | 2022-2023 | Quviviq |
| W. L. Gore & Associates, INC. | $135.95 | 2019 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $133.63 | 2019 | |
| Intuitive Surgical, INC. | $121.16 | 2024 | |
| Abbvie INC. | $112.11 | 2022-2024 | Vraylar |
| Abbott Laboratories | $111.18 | 2024 | Mitraclip |
| Paratek Pharmaceuticals, INC. | $107.45 | 2022-2025 | Nuzyra, Xhance |
| Sumitomo Pharma America, INC. | $104.68 | 2023-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $93.21 | 2023-2025 | Capvaxive, Gardasil 9, Verquvo |
| Exact Sciences Corporation | $87.64 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $63.25 | 2023-2025 | Keveyis |
| Sunovion Pharmaceuticals INC. | $56.96 | 2021-2022 | |
| Ibsa Pharma INC. | $53.22 | 2020 | |
| Corcept Therapeutics | $50.52 | 2022-2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $50.43 | 2024-2025 | Voquezna |
| Radius Health, INC. | $49.20 | 2023-2024 | Tymlos |
| Arthrex, INC. | $45.00 | 2019 | |
| Kvk-Tech, INC. | $41.59 | 2019 | |
| Philips North America LLC | $39.76 | 2024 | (Cm9) Amb Mon & Diag Und |
| Organogenesis INC. | $38.15 | 2025 | Cygnus Dual |
| Insmed, INC. | $32.26 | 2025 | Arikayce |
| Otsuka America Pharmaceutical, INC. | $26.54 | 2023 | Rexulti |
| Sanofi Pasteur INC. | $26.28 | 2023 | |
| Kyowa Kirin, INC. | $25.48 | 2025 | |
| Shield Therapeutics INC | $24.98 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $22.44 | 2021 | |
| Tonix Medicines, INC. | $22.02 | 2025 | Tonmya |
| Genentech USA, INC. | $21.65 | 2019 | |
| Amarin Pharma, INC. | $21.19 | 2020 | |
| Optinose US, INC. | $20.65 | 2022 | |
| Agepha Pharma Fz LLC | $18.74 | 2025 | Lodoco |
| Cmp Pharma, INC. | $17.14 | 2021 | |
| Irhythm Technologies, INC. | $13.56 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.09 | 2023 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavan Anand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.